Home Other Building Blocks 152529-79-8
152529-79-8,MFCD06411605
Catalog No.:AA00APRK

152529-79-8 | 4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1-PROPYL-1H-PURIN-8-YL)-BENZENESULFONIC ACID

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
in stock  
$243.00   $170.00
- +
10mg
95%
in stock  
$341.00   $239.00
- +
25mg
95%
in stock  
$695.00   $487.00
- +
50mg
95%
in stock  
$1,268.00   $888.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00APRK
Chemical Name:
4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1-PROPYL-1H-PURIN-8-YL)-BENZENESULFONIC ACID
CAS Number:
152529-79-8
Molecular Formula:
C14H14N4O5S
Molecular Weight:
350.3498
MDL Number:
MFCD06411605
SMILES:
CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)O
Properties
Computed Properties
 
Complexity:
611  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
4  
XLogP3:
0.7  

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,2004,vol.47,p.1031-1043

[1]JournalofMedicinalChemistry,2002,vol.45,p.1500-1510

[2]JournalofMedicinalChemistry,1993,vol.36,p.3341-3349

Literature

Title: Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.

Journal: Oncotarget 20160927

Title: Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury.

Journal: Anesthesiology 20120601

Title: Detrimental effects of adenosine signaling in sickle cell disease.

Journal: Nature medicine 20110101

Title: Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder.

Journal: Basic & clinical pharmacology & toxicology 20100701

Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.

Journal: The Journal of clinical investigation 20081001

Title: The reno-vascular A2B adenosine receptor protects the kidney from ischemia.

Journal: PLoS medicine 20080601

Title: Caffeine and a selective adenosine A(2B) receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice.

Journal: Neuroscience letters 20080509

Title: A2B adenosine receptor dampens hypoxia-induced vascular leak.

Journal: Blood 20080215

Title: Developmental changes of purinergic control of intestinal motor activity during metamorphosis in the African clawed frog, Xenopus laevis.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20070501

Title: Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.

Journal: Circulation 20070327

Title: A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.

Journal: Journal of medicinal chemistry 20060713

Title: Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice.

Journal: European journal of pharmacology 20060215

Title: Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.

Journal: Journal of medicinal chemistry 20040212

Title: 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.

Journal: Journal of medicinal chemistry 20020328

Title: Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors.

Journal: Journal of medicinal chemistry 19931029

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:152529-79-8 Molecular Formula|152529-79-8 MDL|152529-79-8 SMILES|152529-79-8 4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1-PROPYL-1H-PURIN-8-YL)-BENZENESULFONIC ACID